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Context No previous studies have examined the role of youth calcium intake in the 
development of impaired glucose metabolism, particularly those with long-term high calcium 
intake. 
Objectives To examine whether youth and long-term (between youth and adulthood) dietary 
calcium intake is associated with adult impaired glucose metabolism and T2D. 
Design, Setting, and Participants The Cardiovascular Risk in Young Finns Study (YFS) is a 
31-year prospective cohort study (n=1134, aged 3-18 years at baseline). The Special Turku 
coronary Risk factor Intervention Project (STRIP) is a 20-year prospective, randomized, 
infancy-onset intervention trial; data from age 2 to 20 years were used for observational 
analysis (n=420). 
Exposures Youth and long-term (mean between youth and adulthood) dietary calcium intake. 
In the YFS, dietary calcium intake was assessed at baseline (1980) and adult follow-ups 
(2001, 2007 and 2011). In the STRIP, dietary calcium intake was assessed annually from age 
2 to 20 years. 
Main outcome measures Adult impaired fasting glucose (IFG), high HOMA-IR, high insulin 
levels, and T2D. 
Results We found no evidence for non-linear associations between calcium intake with IFG 
or T2D among females and males (all p for non-linearity>0.05) in neither the YFS or STRIP. 
Higher youth and long-term dietary calcium intake was not associated with the risk of IFG, 
high HOMA-IR, high insulin levels or T2D among females or males after adjustment for 
confounders including youth and adult BMI in neither studies. 
Conclusions Youth or long-term dietary calcium intake is not associated with adult risk of 





Due primarily to the rise in obesity over recent decades, the incidence of type 2 diabetes 
(T2D) has dramatically increased among children and adolescents (herein termed youth)1. As 
a result, it is important that the prevention of T2D begins at an early stage. However, only few 
modifiable risk factors in youth have been examined for their associations with the 
development of adult T2D2. 
Recent data have raised concern that calcium intakes higher than the recommended levels are 
associated with increased risk for cardiovascular diseases3 and mortality4. For T2D, studies 
among adults have demonstrated conflicting results on the association of calcium intake with 
T2D5-7. Moreover, no studies have examined the relationship between calcium intake in youth 
and the risk of developing impaired fasting glucose or T2D in adulthood. This is important as 
calcium requirements vary by age with past studies in adults generally focused on populations 
with low or moderate average calcium intake5-8. In particular, people in Northern European 
countries (e.g., Finland and Iceland) have globally high calcium intake 9. Therefore, we aimed 
to describe the association between calcium intake in youth and from youth to adulthood with 
the risk of developing adult impaired fasting glucose (IFG), high insulin resistance and insulin 
levels, and T2D in two studies among Finns with a generally high calcium intake. 
Methods 
Participants from the two studies were analysed separately. 
The prospective Cardiovascular Risk in Young Finns Study (YFS) 
Participants 
The YFS began in 1980 and was followed up in 2001, 2007 and 2011. At baseline, 3596 
participants aged 3-18 years were randomly selected from the national register of the study 
areas. A 50% random sample of the participants was selected to participate in the dietary 
recall interview (n=1768). Participants who had Type 1 diabetes or were pregnant at each 
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follow-up were excluded from all analyses. The current analyses used data from 1134 
participants who had dietary and risk factor data from baseline, and adult T2D data. All 
participants gave written informed consent, and local ethics committees approved the study. 
T2D and IFG 
Participants were classified as having T2D if they met one of the following: fasting plasma 
glucose ≥7 mmol/L (126 mg/dl); T2D diagnosed by a physician10; HbA1c ≥6.5% (48 
mmol/mol) at the 2011 follow-up; use of glucose-lowering medication at 2007 or 2011 
follow-ups; or being confirmed by National Social Insurance Institution Drug Reimbursement 
Registry. IFG was defined as having a fasting plasma glucose ≥5.6 but ≤6.9 mmol/L using the 
latest available measurement11. 
Dietary intake/Diet 
Diet was assessed by trained dietitians using a 48-hour dietary recall method in 1980 and 
2001, and food frequency questionnaire in 2007 and 2011. We recorded the type and amount 
of food eaten by the participant during the two days prior to the interview12. Special computer 
software was used to calculate dietary calcium intake12. Long-term calcium intake was 
calculated as the mean value of calcium intake in youth (1980) and adulthood (mean of 2001, 
2007, and 2011).  
Other factors 
Height and weight were measured in 1980, 2001, 2007 and 2011 and body mass index (BMI) 
calculated as weight/(height2) (kg/m2). The latest available measures were used as adulthood 
BMI. Baseline serum 25-hydroxyvitamin D (25OHD) levels were measured as previously 
described2. Information on smoking habits was collected during a medical examination in a 
solitary room. Youth smoking for participants aged <12 years in 1980 was defined on a daily 
basis between ages 12-18. For those aged 12-18 years in 1980, youth smoking was defined as 
regular cigarette smoking on a weekly basis (or more often). A physical activity index was 
calculated as previously described13. Briefly, we asked and summed up different variables 
6 
 
about exercise/physical activity habits, including intensity and frequency of exercise, athletic 
club attendance (frequency of participating in training at an athletic club), athletic 
competitions (whether participated in club, district or national level competitions), leisure 
time (usual activities during spare time: indoors, mostly indoors and mostly outdoors) and 
sports participation. A parent-completed questionnaire was used for participants aged 3 and 6 
years, while self-completed questionnaires were used for children aged 9 to 18 years. This 
physical activity measure has been shown to be reliable and valid14. Physical activity indices 
were standardised by age. Questionnaires were used to obtain information on parental history 
of T2D and years of education. 
The Special Turku coronary Risk factor Intervention Project (STRIP) 
Participants 
The STRIP study is an infancy-onset randomized controlled trial of dietary counseling that 
aimed to reduce the risk of atherosclerosis. Participants of the study have been closely 
followed up beginning of age 7 months (between February 1990 and June 1992) to 20 years 
of age. The details of the STRIP study have been described elsewhere1536. Briefly, at baseline 
(February 1990 to June 1992) the families of 5-month-old infants were recruited from well-
baby clinics in Turku, Finland. These families received detailed information about STRIP 
when their infants were 6 months old. A total of 1062 infants participated in the study (56.5% 
of the eligible age cohort), and were randomly assigned to a dietary intervention group 
(N = 540; 256 girls) or a control group (N = 522; 256 girls) when they were aged 7 months. 
During the study visits, all children met with a nutritionist and a pediatrician or a nurse. The 
children in the intervention group received individualised dietary counseling at 1- to 3-month 
intervals until the age of 2 years and biannually thereafter until 20 years of age. The children 
in the control group came to the study visits biannually until the age of 7 years and annually 
thereafter until the age of 20 years. During the study visits, the control group received basic 
health education similar to the education routinely given at Finnish well-baby clinics and by 
school health care. The study was approved by the Joint Commission on Ethics of the Turku 
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University and the Turku University Central Hospital. Written informed consent was obtained 
from the parents in the beginning of the study and from the adolescents at 15 and 18 years of 
age. The present observational analysis included 420 participants who had height and weight 
measured at the age of 2 and 20 years, at least one dietary calcium intake assessment between 
2 and 20 years of age, and one outcome measure available at age 20. 
Impaired glucose metabolism at the age of 20 
Fasting venous blood samples were obtained to determine serum glucose and insulin levels. 
The samples were centrifuged immediately, with 15 μl of the enzyme inhibitor Antagosan 
added to 0.5-ml serum insulin sample. Samples were stored frozen until analysed. Serum 
insulin levels were measured with a microparticle enzyme immunoassay (Insulin IMX system 
reagent, Abbott, [Chicago, IL], interassay coefficient of variation [CV]=6.5%) or with a 
chemiluminescent microparticle immunoassay (ARCHITECT insulin assay, Abbott, USA, 
interassay CV=1.8%)15. A correction of analytical level between the methods was used15. 
Serum glucose was measured by a hexokinase method (Glucose Olympus System Reagent, 
Olympus, Ireland, interassay CV 1.8%). Insulin sensitivity was estimated by HOMA-IR 
(fasting insulin mU/mL×[fasting glucose (mmol/L)/22.5])16. 
IFG was defined as having a fasting glucose ≥5.6 but ≤6.9 mmol/L and T2D as ≥7 mmol/L 
and diagnosed by a physician11. High insulin resistance was defined using a WHO study 
where HOMA index was at or above the 75th sex-specific percentile17. For consistency, high 
fasting insulin was dichotomized using the 75th sex-specific percentile. 
Dietary intake 
Diet was obtained annually between ages 2 and 20 years using 4-day food records 
(consecutive days; at least one weekend day included)18,19, a method validated in children20. 
The food records were reviewed by a nutritionist for accuracy. The nutrient intakes were 
calculated using a Micro Nutrica based on the Food and Nutrient Database of the Social 
Insurance Institution21. The mean calcium intake was calculated for each participant from the 
8 
 
age of 2 to 12 (childhood), 13 to 18 (adolescence) and 2 to 20 (long-term) years. The average 
intakes of fruit and vegetables from the age of 2 to 20 years were also calculated and used in 
analyses. 
Other factors 
Weight was measured using an electronic scale (S10; Soehnle, Murrhardt, Germany) to the 
nearest 0.1 kg and height using a wall-mounted stadiometer (Harpenden Stadiometer, Holtain, 
Crymych, U.K.) to the nearest 0.1 cm. BMI was calculated as weight/(height2) (kg/m2). 
Questionnaires were used to assess current regular smoking (once a day or more often), 
physical activity (metabolic equivalent hours per week of leisure-time physical activity 
calculated by multiplying weekly mean exercise intensity, duration, and frequency)22,23, 
parental history of diabetes, socio-economic status (at least one of the parents had bachelor’s 
degree or higher education when participants were aged 13 months). Latest available values 
for smoking and physical activity were used in analyses. 
Statistical analysis 
Mean (standard deviation) and number (%) were used, as appropriate, to describe variables. 
Univariable and multivariable modified Poisson regression models (using a robust error 
variance) were used to estimate the relative risk (RR) and 95% confidence intervals (CI) for 
youth dietary calcium intake and the risk of adult IFG and T2D in YFS and for long-term 
calcium intake in childhood, adolescent and between childhood and adulthood with the risk of 
IFG, high HOMA-IR and insulin levels in STRIP. All analyses were stratified by sex. We 
selected potential confounders based on the biological plausibility of an association of a factor 
with both the outcome and the exposure of interest, including age, BMI, serum 25OHD 
levels, parental history of diabetes, fruit and vegetable consumption, physical activity, 
smoking, socio-economic status (parent’s years of education) at baseline and adult BMI in 
YFS, and BMI at baseline, long-term consumptions of fruit and vegetables, and BMI at age 
20 years in the STRIP. We used restricted cubic splines to examine the potential non-linear 
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associations between calcium intake and outcomes24. Non-linearity was tested by comparing 
the log-likelihood of the new model with that of the linear model. A cut-off of 800 mg/d (the 
median of recommended intake for youth aged 6-17 years in Finland) was used to estimate 
the RR (95%CIs) of developing IFG and T2D at different calcium intakes. Missing data were 
imputed: adulthood BMI (n=13)and long-term calcium intake (n=198) (YFS); current regular 
smoking (n=157) and parental education (n=66) (STRIP). We assumed all values were 
missing at random. All analyses were performed in Stata version 15.1 (Stata Corporation, 
Texas, USA). A two-tailed p value <0.05 was considered statistically significant. 
Results 
Of the 1134 participants (51% female) in the YFS, 50 developed T2D and 240 developed 
IFG. Table 1 shows the comparison of participants’ characteristics between females and 
males in youth and adulthood. At baseline, the mean intake of dietary calcium was 1019 mg/d 
in females and 1270 mg/d in males; only five participants were taking calcium supplements 
(<0.5 %). The long-term mean intake was 1160 mg/d for females and 1371 mg/d for males. 
We found no evidence of non-linear associations between youth or long-term calcium intake 
and IFG or T2D in females or males (p for non-linearity>0.05 for all, Figure 1 and 2). In 
unadjusted models, higher youth and long-term (youth to adulthood) dietary calcium intake 
was associated with increased risk of IFG and T2D among males but these associations were 
attenuated and no longer statistically significant after adjustment for confounders including 
youth and adult BMI (Table 2). Youth or long-term dietary calcium intake was not associated 
with IFG or T2D among females (Table 2). 
Characteristics of participants in the STRIP are given in Supplemental Table 1. None 
developed T2D. Similarly, there was no evidence of non-linear associations between calcium 
intake and IFG, high HOMA-IR or high insulin levels in females or males (p for non-
linearity>0.05 for all). After adjustment for confounders, the associations of calcium intake in 
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childhood and adolescence, and long-term calcium intake remained non-significant with all 
studied outcomes (Supplemental Table 2, 3 and 4). 
Discussion 
Using data from two independent cohorts with on average high calcium intake, we found that 
neither youth nor long-term (child to adult) dietary calcium intake was associated with 
increased risk of developing IFG, high HOMA-IR, high insulin level or T2D in adulthood. 
Our findings are novel as this is the first study to describe the association of youth and long-
term dietary calcium intake with these outcomes in adulthood in cohorts with a high average 
intake of calcium. These findings suggest that a calcium intake much higher than the 
recommended level (but lower than the tolerable upper intake level) might not confer an 
increased risk of developing impaired glucose metabolism or T2D.  
Important findings and possible explanations 
Findings for the association between calcium intake and risk of T2D in adults have been 
contradictory5-8. Overall, participants in previous studies had a low to moderate average 
intake of calcium with the authors of these works concluding that increased calcium intake 
was not, or was inversely, associated with T2D. For example, Lorenzo et al. found that an 
increased serum calcium level but not dietary calcium intake was associated with increased 
risk of T2D in adults during a mean follow-up of 5.2 years (mean calcium intake=942 mg/d; 
aged 40-69 years)5. In contrast, the Nurses’ Health Study showed that women (aged 30-55 
years, mean calcium intake =731 mg/d) in the highest category of calcium intake (>1200 
mg/d) from all sources had 21% lower risk of developing T2D compared with those in the 
lowest category (≤600 mg/d)6. However, the association of dietary calcium intake with T2D is 
similar to our findings in females in the fully adjusted model. Importantly, the analyses in the 
Nurses’ Health Study were stratified by pre-specified cut-offs, which risk missing important 
associations. For example, it is unclear whether the association is linear and if not, where and 
how the association changes particularly in those with high calcium intake. In the Shanghai 
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Women’s Health Study, similar findings were observed (high calcium intake associated with 
lower risk of T2D) when data were analysed by fifths of calcium intake7. However, the 
average intake of calcium was low (median=466 mg/d). The median calcium intake of the 
highest fifth in the study was only 650 mg/d; much lower than the recommended level for 
adults. Therefore, these previous findings might not apply to populations with higher average 
dietary calcium intake. 
Although the exact mechanisms for the association between calcium and T2D remain unclear, 
those supporting a favourable role of calcium suggest an adverse effect of low serum calcium 
concentration on insulin secretion and other insulin actions8. In contrast, increased serum 
calcium levels were associated with decreased insulin sensitivity but not insulin secretion in 
elderly men, even in participants with normal glucose and normal levels of serum calcium25. 
In line, recent epidemiological studies have found a positive association between increased 
serum calcium levels and the risk of T2D in adults5,26-29. The conflicting evidence may be due 
to the differences in serum calcium levels of the studied population. For example, it has been 
shown that increased serum calcium concentration was only inversely associated with the risk 
of T2D among those with calcium levels >2.38 mmol/l5. In addition, a higher serum calcium 
level may not reflect high calcium intake but rather an indicator of hyperparathyroidism, 
which might be attributed to long-term insulin insufficiency or insulin resistance, leading to 
increased risk of T2D30. Future studies should consider the potential threshold effect of 
calcium intake or serum calcium levels on T2D and related outcomes considering the impact 
of serum parathyroid hormone levels. 
Only a few randomised controlled trials (RCT) have examined the effect of calcium 
supplementation on T2D in adults and the results were also conflicting31,32. In 20 nondiabetic 
patients with essential hypertension, calcium supplementation of 1,500 mg/d vs. placebo for 8 
weeks improved insulin sensitivity but did not affect fasting glycemia32. However, a 2-by-2 
factorial-design RCT of 92 adults found no effect of twice-daily 400 mg calcium 
supplementation (calcium + vitamin D or vitamin D placebo) vs. no calcium (calcium placebo 
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+ vitamin D or vitamin D placebo) for 16 weeks on pancreatic β cell function, acute insulin 
response, insulin sensitivity, or measures of glycemia31. Of note, participants in the control 
group of the smaller RCT were maintained on a low calcium intake (≈500 mg/d) while 
participants in the larger study had a moderate calcium intake at baseline (mean= 976 mg/d). 
These data suggest calcium supplementation might only be effective at reducing the risk of 
T2D among those with low calcium intake. Importantly, it is suggested that calcium 
supplementation but not high intake of dietary calcium increases the risk of cardiovascular 
diseases3. However, our ability of examining calcium supplement is limited due to the low 
rate of supplement (<0.5% in youth and 8% in adulthood in the YFS) and this should be 
examined in future research in people with high rate of calcium supplementation. 
Methodological considerations and limitations 
The strength of this study is the analysis using data from two independent cohorts with long-
term follow-up in a population-based sample, enabling the examination of childhood factors 
with adult health outcomes. Moreover, the STRIP is an infancy-onset study, minimising the 
potential influence of age and age-related factors. The dietary calcium intake in the STRIP 
was assessed annually using a well-validated method, providing an accurate measurement of 
the long-term calcium intake. In the YFS, youth dietary calcium intake was measured by the 
48-hour recall method, which captures limited intra-individual variability. However, the long-
term calcium intake was based on four time points (two time points using food frequency 
questionnaire), partly overcoming this limitation. Moreover, we had a small number of T2D 
patients and participants with very low calcium intake (only 5% <800 mg/d for the long-term 
intake in the YFS and <10% in the STRIP). Therefore, we could not rule out the possible 
association between calcium intake and T2D in those with very low calcium intake. Our total 
sample size is relatively small and studies of similar settings but larger sample size are needed 
to confirm our findings before any potential risk of high calcium intake could be ruled out. 
We had participants lost to follow-up in both cohorts but we have previously shown that these 
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samples are representative of the original cohorts19,33,34. Moreover, multiple imputation was 
used to account for missing data. Lastly, the STRIP is a dietary intervention study and thus 
half of the sample had a healthier diet in terms of e.g. quality of dietary fat compared to the 
control group. Nevertheless, there was no association between the intervention and calcium 
intake, suggesting that our results are likely to be generalisable to a general population.  
Conclusions and policy implications 
In conclusion, dietary calcium intake much higher than the recommended level (but lower 
than the tolerable upper intake levels) in youth and between youth and adulthood is not 
associated with the risk of IFG, high insulin resistance, high insulin levels or T2D in 
adulthood. This finding should be considered in assessing the balance of risks and benefits of 
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Youth   
    Age (year) 10.6 (4.9) 10.5 (5.0) 
    BMI (kg/m2) 17.9 (3.1) 18.0 (3.1) 
    25OHD (nmol/L) 50.3 (15.6) 53.4 (14.7) 
    Dietary calcium intake (mg/d) 1019 (366) 1270 (514) 
    Physical activity index (z score) -0.25 (0.90) 0.22 (1.03) 
    Parental history of diabetes, n (%) 13 (2) 7 (1) 
    Fruit consumption (>6 times/week), n (%) 485 (84) 429 (77) 
    Vegetable consumption (>6 times/week), n (%) 199 (34) 196 (35) 
    Smokers, n (%) 125 (22) 180 (32) 
    Parental years of education 10.1 (3.4) 10.0 (3.3) 
Adulthood b   
    Age (year) 41.6 (4.9) 41.5 (5.0) 
    BMI (kg/m2) 25.7 (5.1) 27.0 (4.1) 
    Smokers, n (%) 94 (16) 119 (22) 
    Education status, n (%)   
        Grammar school 76 (15) 79 (16) 
        College or vocational school 232 (44) 242 (48) 
        University degree 212 (41) 184 (36) 
    Fasting glucose (mmol/L) 5.19 (0.73) 5.54 (0.92) 
    Glucose categories, n (%)   
        NFG 483 (84) 361 (65) 
        IFG 76 (13) 164 (29) 
        T2D 19 (3) 31 (6) 
    Fruit consumption (g/day) 216 (209) 172 (213) 
    Vegetable consumption (g/day) 294 (194) 244 (172) 
Data are mean (standard deviation) unless otherwise stated.  
Abbreviations: NFG, normal fasting glucose; IFG, impaired fasting glucose; T2D, type 2 
diabetes mellitus; BMI, body mass index; 25OHD, 25-hydroxyvitamin D. 
a IFG cut-off is 5.6 mmol/L. 
b all variables used data from the latest available values in adulthood (from 2001, 2007 and 
2011). 
For adult variables, number of participants were 1121 for BMI, 1128 for fasting glucose, 936 
for fruit and vegetable consumption, 1118 for smoking and 1025 for education. 





Table 2 Associations of youth and long-term dietary calcium intake with IFG and T2D in 
adult females and males in the YFS 
   Females   Males 
Youth calcium  n RR (95% CI)a  n RR (95% CI)a 
Model 1 NFG 483 1.00 (Ref)  361 1.00 (Ref) 
 IFG 76 0.90 (0.72, 1.13)  164 1.17 (1.05, 1.30) 
 T2D 19 1.08 (0.73, 1.61)  31 1.55 (1.20, 2.01) 
       
Model 2 NFG 483 1.00 (Ref)  361 1.00 (Ref) 
 IFG 76 0.93 (0.74, 1.17)  164 1.11 (0.99, 1.24) 
 T2D 19 1.12 (0.71, 1.79)  31 1.31 (0.98, 1.75) 
       
Model 3 NFG 483 1.00 (Ref)  361 1.00 (Ref) 
 IFG 76 0.93 (0.74, 1.17)  164 1.11 (0.99, 1.24) 
 T2D 19 1.11 (0.68, 1.80)  31 1.17 (0.83, 1.64) 
Long-term calcium       
Model 1 NFG 483 1.00 (Ref)  361 1.00 (Ref) 
 IFG 76 1.04 (0.84, 1.29)  164 1.14 (1.02, 1.28) 
 T2D 19 1.37 (0.94, 2.00)  31 1.41 (1.01, 1.98)  
       
Model 2 NFG 483 1.00 (Ref)  361 1.0 (Ref) 
 IFG 76 1.11 (0.91, 1.36)  164 1.08 (0.97, 1.21) 
 T2D 19 1.38 (0.98 1.94)  31 1.05 (0.71, 1.53)  
       
Model 3 NFG 483 1.0 (Ref)  361 1.0 (Ref) 
 IFG 76 1.11 (0.90, 1.36)  164 1.09 (0.97, 1.22) 
 T2D 19 1.39 (1.93, 2.06)  31 1.10 (0.72 1.69) 
Abbreviations: RR, relative risk; CI, confidence interval; NFG, normal fasting glucose; IFG, 
impaired fasting glucose (cut-off 5.6 mmol/L); T2D, type 2 diabetes mellitus. 
a relative risk for every standard deviation (youth: 366 mg/d for females and 514 mg/d for 
males; long-term: 302 mg/d for females and 387 mg/d for males) higher dietary calcium 
intake. 
Bold denotes statistical significance, p<0.05. 
Model 1, unadjusted; Model 2, adjusted for age and childhood and adulthood body mass 
index; Model 3, model 2 + baseline serum 25OHD levels, parental history of diabetes, fruit 










Figure 1 Restricted cubic splines for the non-linear associations between youth dietary 
calcium intake, IFG and T2D in females (A and B) and males (C and D) in the YFS. A 
calcium intake of 800 mg/d was used as the reference to estimate the relative risk of 
developing IFG and T2D at different calcium intakes. Solid and dashed lines denote relative 
risks and corresponding 95% confidence intervals. 
 
Figure 2 Restricted cubic splines for the non-linear associations between long-term dietary 
calcium intake, IFG and T2D in females (A and B) and males (C and D) in the YFS. A 
calcium intake of 800 mg/d was used as the reference to estimate the relative risk of 
developing IFG and T2D at different calcium intakes. Solid and dashed lines denote relative 



















 2 years old 16.4 (1.4) 16.5 (1.3) 
 13 years old 19.6 (3.3) 19.1 (3.0) 
 20 years old 22.8 (4.2) 23.0 (3.6) 
Average calcium intake (mg/d) 
 Childhood (2-12 years old) 1003 (186) 1067 (174) 
 Adolescence (13-18 years old) 1106 (324) 1349 (359) 
 Long-term (2-20 years old) 1037 (208) 1177 (217) 
Average consumption of fruits, 2-20 years old (g/d) 188 (76) 173 (80) 
Average consumption of vegetables, 2-20 years old (g/d) 182 (45) 203 (55) 
Current smoking (yes) 25 (21) 27 (19) 
Physical activity (MET/week) 23 (21) 26 (25) 
Parental diabetes (yes), n (%) 23 (11) 24 (12) 
Parental education, n (%) a 133 (72) 118 (70) 
IFG, n (%) 9 (4.2) 10 (4.9) 
Fasting glucose (mmol/L) 4.76 (0.42) 4.93 (0.42) 
HOMA-IR 1.59 (1.02) 1.68 (2.08) 
Fasting insulin level (mIU/L) 7.38 (4.24) 7.37 (6.22) 
BMI, body mass index; MET, metabolic equivalent; IFG, impaired fasting glucose. 
n=263 for current smoking; 354 for parent education. 
Values are mean (standard deviation) unless otherwise stated. 
a at least one of the parents had bachelor’s degree or higher education (master or PhD). 
Bold denotes significant difference between females and males, p<0.05. 
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Supplemental Table 2 Associations of childhood (2-12 years old) dietary calcium intake 
with IFG, insulin resistance and insulin levels in adult females and males in the STRIP 
 Outcomes  Females   Males 
  n RR (95% CI)a  n RR (95% CI)a 
Model 1 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.63 (0.30, 1.31)  10 0.93 (0.54, 1.60) 
       
Model 2 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.55 (0.29, 1.05)  10 0.99 (0.51, 1.92) 
       
Model 3 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.69 (0.41, 1.14)  10 0.99 (0.53, 1.87) 
       
Model 1 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.15 (0.85, 1.54)  49 1.00 (0.76, 1.32) 
       
Model 2 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.07 (0.79, 1.44)  49 1.07 (0.80, 1.42) 
       
Model 3 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.12 (0.85, 1.47)  49 1.12 (0.86, 1.47) 
       
Model 1 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.16 (0.87, 1.55)  48 0.95 (0.71, 1.26) 
       
Model 2 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.05 (0.79, 1.41)  48 1.01 (0.75, 1.37) 
       
Model 3 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.07 (0.81, 1.42)  48 1.07 (0.80, 1.42) 
Abbreviations: RR, relative risk; CI, confidence interval; NFG, normal fasting glucose; IFG, 
impaired fasting glucose (cut-off 5.6 mmol/L). 
a relative risk for every standard deviation (186 mg/d for females and 174 mg/d for males) 
increase in calcium intake. 
Model 1, unadjusted; Model 2, adjusted for body mass index at 2 and 20 years old; Model 3, 




Supplemental Table 3 Associations of adolescent (13-18 years old) dietary calcium intake 
with IFG, insulin resistance and insulin levels in adult females and males in the STRIP 
 Outcomes  Females   Males 
  n RR (95% CI)a  n RR (95% CI)a 
Model 1 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.67 (0.36, 1.25)  10 0.87 (0.40, 1.89) 
       
Model 2 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.67 (0.34, 1.33)  10 0.95 (0.50, 1.82) 
       
Model 3 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.77 (0.37 1.57)  10 0.94 (0.46, 1.93) 
       
Model 1 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.02 (0.77, 1.36)  49 0.85 (0.67, 1.07) 
       
Model 2 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.16 (0.88, 1.54)  49 0.88 (0.70, 1.12) 
       
Model 3 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.20 (0.90, 1.60)  49 0.95 (0.74, 1.23) 
       
Model 1 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 0.95 (0.72, 1.26)  48 0.75 (0.59, 0.94) 
       
Model 2 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.08 (0.82, 1.42)  48 0.80 (0.63, 1.01) 
       
Model 3 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.11 (0.84, 1.46)  48 0.85 (0.65, 1.10) 
Abbreviations: RR, relative risk; CI, confidence interval; NFG, normal fasting glucose; IFG, 
impaired fasting glucose (cut-off 5.6 mmol/L). 
Bold denotes statistical significance, p<0.05. 
a relative risk for every standard deviation (324 mg/d for females and 359 mg/d for males) 
increase in calcium intake. 
Model 1, unadjusted; Model 2, adjusted for body mass index at 2 and 20 years old; Model 3, 




Supplemental Table 4 Association of long-term (2-20 years old) dietary calcium intake with 
IFG, insulin resistance and insulin levels in adult females and males in the STRIP 
 Outcomes  Females   Males 
  n RR (95% CI)a  n RR (95% CI)a 
Model 1 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.62 (0.30, 1.27)  10 0.83 (0.44, 1.58) 
       
Model 2 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.58 (0.28, 1.20)  10 0.93 (0.4249 1.78) 
       
Model 3 NFG 207 1.00 (Ref)  194 1.00 (Ref) 
 IFG 9 0.70 (0.42, 1.17)  10 0.93 (0.50, 1.73) 
       
Model 1 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.09 (0.82, 1.46)  49 0.90 (0.70, 1.16) 
       
Model 2 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.09 (0.80, 1.46)  49 0.99 (0.78, 1.26) 
       
Model 3 Low HOMA-IR 165 1.00 (Ref)  155 1.00 (Ref) 
 High HOMA-IR 51 1.15 (0.86, 1.53)  49 1.07 (0.84, 1.37) 
       
Model 1 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.07 (0.80, 1.41)  48 0.80 (0.62, 1.04) 
       
Model 2 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.05 (0.78, 1.40)  48 0.89 (0.69, 1.14) 
       
Model 3 Low insulin level 164 1.00 (Ref)  156 1.00 (Ref) 
 High insulin level 52 1.08 (0.80, 1.46)  48 0.96 (0.74, 1.27) 
Abbreviations: RR, relative risk; CI, confidence interval; NFG, normal fasting glucose; IFG, 
impaired fasting glucose (cut-off 5.6 mmol/L). 
a relative risk for every standard deviation (208 mg/d for females and 217 mg/d for males) 
increase in calcium intake. 
Model 1, unadjusted; Model 2, adjusted for body mass index at 2 and 20 years old; Model 3, 
model 2 + average consumptions of fruit and vegetables from 2 to 20 years old. 
